Graham Belgrave is Senior Vice President, Head of Global Medical and Regulatory Affairs and Managing Director Europe at Advanced Clinical. He has over 39 years of experience successf
The pharmaceutical industry has sometimes been a laggard in terms of digital maturity, but the COVID-19 crisis has provided companies the impetus to rapidly implement the most cutting-edge
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh